CASI Pharmaceuticals Inc. (CASI)
NASDAQ: CASI
· Real-Time Price · USD
2.18
-0.08 (-3.54%)
At close: Aug 19, 2025, 3:59 PM
2.17
-0.46%
After-hours: Aug 19, 2025, 04:04 PM EDT
-3.54% (1D)
| Bid | 2.16 |
| Market Cap | 33.77M |
| Revenue (ttm) | 31.37M |
| Net Income (ttm) | -40.48M |
| EPS (ttm) | -2.41 |
| PE Ratio (ttm) | -0.9 |
| Forward PE | -1.01 |
| Analyst | Buy |
| Ask | 2.55 |
| Volume | 56,529 |
| Avg. Volume (20D) | 1,317,712 |
| Open | 2.19 |
| Previous Close | 2.26 |
| Day's Range | 2.11 - 2.25 |
| 52-Week Range | 1.09 - 7.67 |
| Beta | 0.61 |
About CASI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CASI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CASI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
CASI Pharmaceuticals Inc. is scheduled to release its earnings on
Sep 2, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+51.16%
CASI Pharmaceuticals shares are trading higher aft...
Unlock content with
Pro Subscription
4 months ago
+0.95%
CASI Pharmaceuticals shares are trading higher after the company received a $20 million proposal from CEO Dr. Wei-Wu He to acquire its business operations in China.
